Publication Name	World Journal of Methodology
Manuscript ID	98912
Country	Taiwan

Received	2024-08-22 08:54
Peer-Review Started	2024-07-09 06:48
To Make the First Decision
Return for Revision	2024-09-30 11:50
Revised	2024-10-11 06:34
Second Decision	2024-10-23 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-23 11:58
Articles in Press	2024-10-23 11:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-11-01 08:56
Publish the Manuscript Online	2024-11-27 10:57

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Editorial
Article Title	Enhancing the outcomes of diabetic vitrectomy with pharmacological adjuvants
Manuscript Source	Invited Manuscript
All Author List	Chun-Yao Cheng, Wen-Rui Hao and Tzu-Hurng Cheng
Funding Agency and Grant Number
Corresponding Author	Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung City 404328, Taiwan. thcheng@mail.cmu.edu.tw
Key Words	Diabetic vitrectomy; Pharmacological adjuvants; Surgical outcomes; Diabetic retinopathy; Clinical implications
Core Tip	Incorporating pharmacological adjuvants into diabetic vitrectomy can significantly enhance surgical outcomes and postoperative recovery. These therapies reduce intraoperative complications like bleeding and improve surgical precision while minimizing postoperative issues, including inflammation and fibrosis. Therefore, the incorporation of these adjunctive treatments into routine clinical practice is crucial for improving patient care, lowering complication rates, and enhancing long-term visual outcomes for those undergoing diabetic vitrectomy.
Publish Date	2024-11-27 10:57
Citation	<p>Cheng CY, Hao WR, Cheng TH. Enhancing the outcomes of diabetic vitrectomy with pharmacological adjuvants. <i>World J Methodol</i> 2025; 15(2): 98912</p>
URL	https://www.wjgnet.com/2222-0682/full/v15/i2/98912.htm
DOI	https://dx.doi.org/10.5662/wjm.v15.i2.98912

Full Article (PDF)	WJM-15-98912-with-cover.pdf
Manuscript File	98912_Auto_Edited_054913.docx
Answering Reviewers	98912-answering-reviewers.pdf
Audio Core Tip	98912-audio.mp3
Conflict-of-Interest Disclosure Form	98912-conflict-of-interest-statement.pdf
Copyright License Agreement	98912-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	98912-non-native-speakers.pdf
Peer-review Report	98912-peer-reviews.pdf
Scientific Misconduct Check	98912-scientific-misconduct-check.png
Scientific Editor Work List	98912-scientific-editor-work-list.pdf
CrossCheck Report	98912-crosscheck-report.pdf